You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 22, 2025

Drug Price Trends for NDC 81520-0100


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 81520-0100

Drug Name NDC Price/Unit ($) Unit Date
VOQUEZNA 10 MG TABLET 81520-0100-30 21.81142 EACH 2025-01-01
VOQUEZNA 10 MG TABLET 81520-0100-30 20.77278 EACH 2024-12-18
VOQUEZNA 10 MG TABLET 81520-0100-30 20.79833 EACH 2024-11-20
VOQUEZNA 10 MG TABLET 81520-0100-30 20.79972 EACH 2024-10-23
VOQUEZNA 10 MG TABLET 81520-0100-30 20.81322 EACH 2024-09-18
VOQUEZNA 10 MG TABLET 81520-0100-30 20.79191 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 81520-0100

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 81520-0100

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a drug identified by the NDC 81520-0100, it is crucial to first understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. For the NDC 81520-0100, the segments break down as follows:

  • Labeler Code: The first segment (81520) is assigned by the FDA and identifies the firm that manufactures, repacks, relabels, or distributes the drug under its own name.
  • Product Code: The second segment (0100) identifies a specific strength, dosage form, and formulation of the drug for the particular firm.
  • Package Code: The third segment (0) identifies the package size and type[1][4].

Market Trends in Prescription Drug Prices

General Price Increases

Prescription drug prices have been a subject of significant scrutiny due to their consistent increases over the years. From January 2022 to January 2023, the average list price increase for single-source drugs was 7.4%, while multi-source drugs saw an average increase of 26.0%[2].

Segment-Specific Trends

  • Single-Source vs. Multi-Source Drugs: Single-source drugs, which are typically brand-name drugs, tend to have lower percentage price increases but higher absolute dollar increases compared to multi-source drugs, which include generics. For instance, the average price change for single-source drugs from January 2022 to January 2023 was $958, while for multi-source drugs it was $69, despite the latter having a higher percentage increase[2].
  • High-Cost Drugs: Drugs with high list prices tend to drive the overall dollar value of price increases. For example, in 2022, the highest dollar value increase was for a drug treating spinal muscular atrophy, with a price increase from $2.12 million to $2.18 million per kit[2].

International Price Comparisons

The U.S. market stands out for its high prescription drug prices compared to other regions. In 2022, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is not just due to higher prices for the same drugs but also because the U.S. market has a drug mix that skews towards more expensive drug compounds[3].

Price Projections for NDC 81520-0100

Historical Price Data

To project future prices for the drug with NDC 81520-0100, it is essential to analyze historical price data. However, without specific historical data for this NDC, we can infer trends from similar drugs.

  • Generic Drugs: If the drug is a generic, it might follow the trend of higher percentage price increases observed in generic drugs. For example, in 2022, the median price increase for generic drugs was 19.9%, with some generics experiencing dramatic increases, such as a 2,527% increase for a generic naproxen[5].

Market Factors Influencing Price

Several factors can influence the price of a drug:

  • Regulatory Environment: Changes in regulatory policies or transparency requirements can impact pricing strategies. For instance, drug price transparency laws can lead to more detailed reporting of price increases and reasons behind them[5].
  • Market Competition: The level of competition in the market can significantly affect prices. Multi-source drugs, which have multiple manufacturers, tend to have higher percentage price increases but lower absolute dollar increases compared to single-source drugs[2].
  • Economic Conditions: Economic indicators such as inflation and consumer price indexes (CPI) can also influence drug prices. For example, the average price increase for drugs in the U.S. from 2017 to 2022 was 14%, which is higher than the CPI-U (Consumer Price Index for all Urban Consumers) increase during the same period[3].

Projected Price Increases

Given the general trends:

  • Percentage Increase: If the drug follows the median increase for generic drugs, it could see a percentage increase in the range of 19.9% to 26.0% per year.
  • Absolute Dollar Increase: The absolute dollar increase would depend on the current list price of the drug. For instance, if the current list price is relatively low, even a high percentage increase might result in a moderate absolute dollar increase.

Example Projection

Assuming the drug with NDC 81520-0100 is a generic with a current list price of $100 per unit:

  • Percentage Increase: A 20% increase would result in a new list price of $120 per unit.
  • Absolute Dollar Increase: This would be a $20 increase per unit.

Key Takeaways

  • NDC Structure: The NDC 81520-0100 identifies the labeler, product, and package size uniquely.
  • Market Trends: Prescription drug prices, especially for generics, have seen significant percentage increases.
  • International Comparisons: U.S. drug prices are notably higher than those in other regions.
  • Price Projections: Future prices can be projected based on historical trends, regulatory environment, market competition, and economic conditions.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product.

How are NDCs assigned?

The first segment (labeler code) is assigned by the FDA, while the second (product code) and third (package code) segments are assigned by the firm[1][4].

Why are U.S. drug prices higher than in other countries?

U.S. drug prices are higher due to a combination of factors including higher list prices for the same drugs and a drug mix that skews towards more expensive compounds[3].

What factors influence drug price increases?

Factors include regulatory environment, market competition, and economic conditions such as inflation and CPI[2][3].

How can historical price data help in projecting future prices?

Historical price data provides trends and patterns that can be used to estimate future price increases based on similar drugs and market conditions.

Are NDCs indicative of FDA approval?

No, assignment of an NDC number does not denote FDA approval of the product. It is merely a unique identifier[4].

Sources

  1. FDA: National Drug Code Database Background Information - FDA
  2. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023
  3. ASPE: International Market Size and Prices
  4. Find-A-Code: NDC Codes - National Drug Codes
  5. Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations 2022
Last updated: 2024-12-30

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.